Picture of Cerus logo

CERS — Cerus News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapHigh Flyer

Cerus Corp expected to post a loss of 8  cents a share - Earnings Preview

* Cerus Corp  CERS.OQ   CERS.O  is expected to show a rise
in
quarterly revenue when it reports  results on February 22. 
    * The Concord California-based  company is expected to
report  a
31.7% increase in revenue to $44.225 million from $33.59 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Cerus Corp is for a
loss
of 8 cents per share. For the same quarter last year, the
company reported a loss of 9 cents per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cerus Corp
is
$10​, about 46% above​ its last closing price of $5.40. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.10       -0.09      -0.07     Beat    26.3
 Jun. 30 2021  -0.10       -0.09      -0.09     Met     5.3
 Mar. 31 2021  -0.10       -0.09      -0.10     Missed  -8.7​
 Dec. 31 2020  -0.09       -0.09      -0.09     Met     -2.3
 ​​Sep.        -0.10       -0.10      -0.08     Beat    23.1
 30 2020                                                
 Jun. 30 2020  -0.11       -0.11      -0.09     Beat    16.3​
 Mar. 31 2020  -0.10       -0.10      -0.10     Met     2
 Dec. 31 2019  -0.12       -0.11      -0.12     Missed  -4.3
 This summary was machine generated February 18 at 21:43 GMT. 
All figures in US dollars  unless otherwise stated

Recent news on Cerus

See all news